Enhanced S100A4 protein expression is clinicopathologically significant to metastatic potential and p53 dysfunction in colorectal cancer

Oncology Reports

Volumn 22, Issue 1, 2009, Pages 41-47

  Kim, Joo Heon ^a   Kim, Chang Nam ^a   Kim, Soo Young ^a   Lee, Jung Sam ^a   Cho, Daeho ^b   Kim, Jae Wha ^c   Yoon, Sun Young ^b  

^a Eulji University School of Medicine   (South Korea)

^b Sookmyung Women's University   (South Korea)

^c Korea Research Institute of Bioscience and Biotechnology (KRIBB)   (South Korea)

Author keywords

Colorectal carcinoma; Metastasis; P53 transactivation; S100A4

Indexed keywords

CALVASCULIN; MESSENGER RNA; PROTEIN P53;

ADULT; ARTICLE; BINDING AFFINITY; CALCIUM BINDING; CANCER INVASION; COLORECTAL CANCER; CONTROLLED STUDY; DISTANT METASTASIS; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPH NODE; MAJOR CLINICAL STUDY; MALE; METASTASIS POTENTIAL; PATHOLOGY; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN MODIFICATION; PROTEIN STABILITY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TRANSACTIVATION; UPREGULATION;

CALCIUM; CARCINOMA; COLORECTAL NEOPLASMS; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HCT116 CELLS; HUMANS; IMMUNOHISTOCHEMISTRY; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NEOPLASM INVASIVENESS; PROTEIN STABILITY; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; S100 PROTEINS; TRANSCRIPTIONAL ACTIVATION; TRANSFECTION; TUMOR MARKERS, BIOLOGICAL; TUMOR SUPPRESSOR PROTEIN P53; UP-REGULATION;

EID: 68349122566     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or_00000404     Document Type: Article

References (29)

1. Landis SH, Murray T, Bolden S and Wingo PA: Cancer statistics, 1998. CA Cancer J Clin 48: 6-29, 1998.
2. Gayet J, Zhou XP, Duval A, et al: Extensive characterization of genetic alterations in a series of human colorectal cancer cell lines. Oncogene 20: 5025-5032, 2001.
3. Kinzler KW and Vogelstein B: Lessons from hereditary colorectal cancer. Cell 87: 159-170, 1996.
4. Shih IM, Zhou W, Goodman SN, Lengauer C, Kinzler KW and Vogelstein B: Evidence that genetic instability occurs at an early stage of colorectal tumorigenesis. Cancer Res 61: 818-822, 2001.
5. McLeod HL and Murray GI: Tumour markers of prognosis in colorectal cancer. Br J Cancer 79: 191-203, 1999.
6. Gongoll S, Peters G, Mengel M, et al: Prognostic significance of calcium-binding protein S100A4 in colorectal cancer. Gastroenterology 123: 1478-1484, 2002.
7. Bronckart Y, Decaestecker C, Nagy N, et al: Development and progression of malignancy in human colon tissues are correlated with expression of specific Ca(2+)-binding S100 proteins. Histol Histopathol 16: 707-712, 2001.
8. Takenaga K, Nakanishi H, Wada K, et al: Increased expression of S100A4, a metastasis-associated gene, in human colorectal adenocarcinomas. Clin Cancer Res 3: 2309-2316, 1997.
9. Schafer BW and Heizmann CW: The S100 family of EF-hand calcium-binding proteins: functions and pathology. Trends Biochem Sci 21: 134-140, 1996.
10. Barraclough R: Calcium-binding protein S100A4 in health and disease. Biochim Biophys Acta 1448: 190-199, 1998.
11. Takenaga K, Nakamura Y, Sakiyama S, Hasegawa Y, Sato K and Endo H: Binding of pEL98 protein, ah S100-related calcium-binding protein, to nonmuscle tropomyosin. J Cell Biol 124: 757-768, 1994.
12. Kriajevska M, Tarabykina S, Bronstein I, et al: Metastasis-associated Mts1 (S100A4) protein modulates protein kinase C phosphorylation of the heavy chain of nonmuscle myosin. J Biol Chem 273: 9852-9856, 1998.
13. Kriajevska M, Fischer-Larsen M, Moertz E, et al: Liprin beta 1, a member of the family of LAR transmembrane tyrosine phosphatase-interacting proteins, is a new target for the metastasis-associated protein S100A4 (Mts1). J Biol Chem 277: 5229-5235, 2002.
14. Chen H, Fernig DG, Rudland PS, Sparks A, Wilkinson MC and Barraclough R: Binding to intracellular targets of the metastasis-inducing protein, S100A4 (p9Ka). Biochem Biophys Res Commun 286: 1212-1217, 2001.
15. Grigorian M, Andresen S, Tulchinsky E, et al: Tumor suppressor p53 protein is a new target for the metastasis-associated Mts1/S100A4 protein: functional consequences of their interaction. J Biol Chem 276: 22699-22708, 2001.
16. Ninomiya I, Ohta T, Fushida S, et al: Increased expression of S100A4 and its prognostic significance in esophageal squamous cell carcinoma. Int J Oncol 18: 715-720, 2001.
17. Yonemura Y, Endou Y, Kimura K, et al: Inverse expression of S100A4 and E-cadherin is associated with metastatic potential in gastric cancer. Clin Cancer Res 6: 4234-4242, 2000.
18. Taylor S, Herrington S, Prime W, Rudland PS and Barraclough R: S100A4 (p9Ka) protein in colon carcinoma and liver metastases: association with carcinoma cells and T-lymphocytes. Br J Cancer 86: 409-416, 2002.
19. Platt-Higgins AM, Renshaw CA, West CR, et al: Comparison of the metastasis-inducing protein S100A4 (p9ka) with other prognostic markers in human breast cancer. Int J Cancer 89: 198-208, 2000.
20. Rudland PS, Platt-Higgins A, Renshaw C, et al: Prognostic significance of the metastasis-inducing protein s100A4 (p9Ka) in human breast cancer. Cancer Res 60: 1595-1603, 2000.
21. Kimura K, Endo Y, Yonemura Y, et al: Clinical significance of S100A4 and E-cadherin-related adhesion molecules in non-small cell lung cancer. Int J Oncol 16: 1125-1131, 2000.
22. Wittekind C, Compton CC, Greene FL and Sobin LH: TNM residual tumor classification revisited. Cancer 94: 2511-2516, 2002.
23. Chomczynski P and Sacchi N: Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 162: 156-159, 1987.
24. Kim EJ and Helfman DM: Characterization of the metastasis-associated protein, S100A4. Roles of calcium binding and dimerization in cellular localization and interaction with myosin. J Biol Chem 278: 30063-30073, 2003.
25. Chen TM and Defendi V: Functional interaction of p53 with HPV18 E6, c-myc and H-ras in 3T3 cells. Oncogene 7: 1541-1547, 1992.
26. Ludes-Meyers JH, Subler MA, Shivakumar CV, et al: Transcriptional activation of the human epidermal growth factor receptor promoter by human p53. Mol Cell Biol 16: 6009-6019, 1996.
27. Horak E, Smith K, Bromley L, et al: Mutant p53, EGF receptor and c-erbB-2 expression in human breast cancer. Oncogene 6: 2277-2284, 1991.
28. Xu J and Morris GF: p53-mediated regulation of proliferating cell nuclear antigen expression in cells exposed to ionizing radiation. Mol Cell Biol 19: 12-20, 1999.
29. Zhan M, Yu D, Lang A, Li L and Pollock RE: Wild type p53 sensitizes soft tissue sarcoma cells to doxorubicin by down-regulating multidrug resistance-1 expression. Cancer 92: 1556-1566, 2001.